期刊文献+

吸入二丙酸倍氯米松纳米微囊的肺内分布及血药浓度测定 被引量:3

Pulmonary distribution of beclomethasone dipropionate nanocapsule in guinea pigs after spray inhalation
下载PDF
导出
摘要 目的 :了解二丙酸倍氯米松聚乳酸聚乙醇酸 (BDP PL GA)纳米微囊体内分布和释药情况。方法 :豚鼠雾化吸入荧光素钠标记的 BDP纳米微囊 ,10分钟后观察其在肺组织中的分布。给豚鼠气管插管后、用喷雾法给予 BDP纳米微囊及普通制剂悬液 ,不同时间点取血及肺组织 ,用高压液相色谱法测定血浆及肺组织匀浆BDP浓度。结果 :雾化吸入 BDP纳米微囊后能较快进入肺泡组织。肺组织匀浆中 ,BDP普通制剂组 BDP峰浓度出现在 8小时左右 ,然后较快下降 ;BDP纳米微囊组释药呈双相动力学过程 :给药后 0 .5~ 1.0小时有一个相对的爆破释放 ,8小时左右达峰浓度 ,12小时开始 BDP浓度明显高于普通制剂组 ,并维持相当高浓度的平台期至 72小时。血浆中普通制剂组和纳米微囊组 BDP浓度均未测出。结论 :吸入给药后 ,肺组织中 BDP纳米微囊制剂能进入肺泡组织 ,并具有良好的缓释性且局部药物浓度明显高于血浆 。 Objective:To investigate the kinetics and distribution of beclomethasone dipropionate(BDP) nanocapsule in vivo.Methods:The pulmonary distribution was observed after spray inhalation of sodium fluoresencelabelled BDPpolydllactidecoglycolide acid(PLGA) nanocapsules at 10 minutes.Healthy guinea pigs were spray inhaled BDP PLGA nanocapsules after intratracheal intubation.BDP concentrations were detected at different time points in both plasma and lung tissue homogenates by high press liquid chromatography (HPLC).Results: Spray inhaled BDP nanocapsule was distributed hemogeneously.In lung tissue homogenates,the peak concentration of BDP was present at about 8 hours and then descended rapidly.In contrast,the release of BDP of BDP PLGA nanocapsules in vivo revealed biphasic kinetics,showing relatively rapid burstrelease at 0.51.0 hour, peaking at about 8 hours,followed by a high plateau of slowrelease up to 72 hours.However,BDP concentrations of both conventional preparation and BDPPLGA nanocapsules were not detected in plasma. Conclusions: BDP PLGA nanocapsules may be suitable for longterm inhaled therapy because of the good controlled release and lower concentrations of BDP in plasma.
出处 《中国危重病急救医学》 CAS CSCD 2002年第8期468-470,共3页 Chinese Critical Care Medicine
基金 国家自然科学基金资助项目 (No.3 9970 712 )
关键词 二丙酸倍氯米松 纳米微囊 高压液相色谱法 雾化吸入法 BDP 血药浓度 测定 beclomethasone dipropionate nanocapsule high press liquid chromatography spray inhalation
  • 相关文献

参考文献2

  • 1李明华 殷凯生 等.哮喘病药物治疗学,第1版[M].北京:人民卫生出版社,1998.170-175.
  • 2平其能.现代药剂学,第1版[M].北京:中国医药科技出版社,1999.625-639.

共引文献1

同被引文献71

  • 1孙铭,杜智,孙洪范,方淑昌,周立波,毕海英,宋继昌.胰岛素纳米粒子缓释制剂的实验研究[J].生物医学工程与临床,2001,5(4):188-192. 被引量:3
  • 2常津.具有靶向抗癌功能的纳米高分子材料───阿霉素免疫磁性毫微粒的体内磁靶向定位试验[J].中国生物医学工程学报,1996,15(4):354-359. 被引量:32
  • 3徐辉碧 杨祥良 等.雄黄抑制小鼠肉瘤S180的尺寸效应的初步研究[J].武汉大学学报:自然科学版,2000,:288-289.
  • 4冯玉麟.难治性哮喘[M].北京:人民卫生出版社,2001.133-142.
  • 5Zhang Y,Kolher N,Zhang M.Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake[J].Biomaterials,2002,23(7):1553-1561.
  • 6Jordan A,Scholz R,Wust P,et al.Effects of magnetic fluid hyperthermia(MFH)on C3H mammary carcinoma in vivo[J].Int J Hyperthermia,1997,13(6):587-605.
  • 7Kreuter J.Namoparticle systems for brain delivery of drugs[J].Adv Drug Deliv Rev,2001,47(1):65-81.
  • 8Schroder U,Sabel BA.Nanoparticles,a drug carrier system to pass the blood-brain barrier,permit central analgesic effects of i.v dalargin injection[J].Brain Res,1996,710(1-2):121.
  • 9Schroeder U,Schroeder H,Sabel BA.Body distribution of 3Hlabelled dalargin bound to poly(butyl caynoacrylate nanoparticles)after iv injections to mice[J].Life Sci,2000,66(6):495-502.
  • 10Cavalli R,Bargoni A,Gasco MR,et al.Duodenal administration of solid lipid nanoparticles loaded with different percentages of tobramycin[J].J Pharm Sci,2003,92(5):1085-1094.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部